4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-052277
COO & Chief Financial Officer sold 22,000 shares at an average $95.31 ($2,096,779)
- COO & Chief Financial Officer acquired 52,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LOWE CHRISTOPHER P. · COO & Chief Financial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-16 | Exercise or conversion : show line 1 in the form | +22,000 | $2.23 | $49,060 | 52,000 | D |
| 2021-08-16 | Sale : show line 2 in the form | −9,158 | $94.23 | $862,958 | 42,842 | D |
| 2021-08-16 | Sale : show line 3 in the form | −7,335 | $95.02 | $696,972 | 35,507 | D |
| 2021-08-16 | Sale : show line 4 in the form | −2,330 | $96.32 | $224,426 | 33,177 | D |
| 2021-08-16 | Sale : show line 5 in the form | −1,100 | $97.28 | $107,008 | 32,077 | D |
| 2021-08-16 | Sale : show line 6 in the form | −2,077 | $98.90 | $205,415 | 30,000 | D |
| 2021-08-17 | Exercise or conversion : show line 7 in the form | +30,000 | $2.23 | $66,900 | 60,000 | D |
| Open-market sales · 22,000 sh · avg $95.31 · $2,096,779 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-16 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −22,000 | 163,294 | D |
| 2021-08-17 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −30,000 | 133,294 | D |
Loading xslF345X03/doc4.xml…